What are the recommended pediatric doses of diazepam for acute seizure control, anxiety, muscle spasm, and procedural sedation?

Pediatric Diazepam Dosing

For acute seizure control in children, administer diazepam intravenously at 0.2–0.5 mg/kg every 2–5 minutes (maximum 5 mg for children <5 years; maximum 10 mg for children ≥5 years), or rectally at 0.5 mg/kg (maximum 20 mg) when IV access is unavailable. 1

Status Epilepticus and Acute Seizure Control

Intravenous Administration (Preferred Route)

• Infants >30 days to <5 years: 0.2–0.5 mg/kg IV slowly every 2–5 minutes, maximum total dose 5 mg 1
• Children ≥5 years: 1 mg/kg IV every 2–5 minutes, maximum total dose 10 mg 1
• Administration technique: Inject slowly over at least 1 minute per 5 mg to minimize respiratory depression and injection-site pain 1
• Repeat dosing: May repeat at 10–15 minute intervals up to maximum dose of 30 mg in adults; pediatric repeat dosing follows same weight-based limits 1
• Follow-up therapy required: Diazepam's anticonvulsant effect lasts only 15–20 minutes due to rapid redistribution; immediately administer a long-acting agent (phenytoin, fosphenytoin, or phenobarbital) after seizure control 2

Rectal Administration (When IV Access Unavailable)

• Dose: 0.5 mg/kg rectally as a single dose, maximum 20 mg 2
• Efficacy: 81% of children stop seizing after a single rectal dose (0.16–0.57 mg/kg range), though 30.8% experience recurrence before hospital arrival 3
• Administration method: Use 5F feeding tube with syringe or lubricated tuberculin syringe inserted 4–5 cm into rectum 3
• Comparative safety: Rectal diazepam produces less respiratory depression than IV diazepam (0% vs. 13% requiring prehospital intubation) 3

Critical Safety Monitoring

• Respiratory support: Have bag-valve-mask, oxygen, and intubation equipment immediately available before administration 1
• Continuous monitoring: Pulse oximetry and respiratory effort must be monitored throughout treatment 2
• Apnea risk: Significantly increased when combined with opioids or other sedatives; reduce doses of both agents when co-administered 4, 2
• Flumazenil availability: Keep reversal agent at bedside, recognizing it will also reverse anticonvulsant effect and may precipitate seizure recurrence 2, 1

Muscle Spasm (Tetanus, Cerebral Palsy, Athetosis)

• Infants >30 days: 1–2 mg IM or IV slowly, repeated every 3–4 hours as necessary 1
• Children ≥5 years: 5–10 mg IM or IV, repeated every 3–4 hours as necessary 1
• Tetanus caveat: Larger doses may be required; respiratory assistance must be available 1

Anxiety and Procedural Sedation

Moderate Anxiety

• Dose: 2–5 mg IM or IV, repeat in 3–4 hours if necessary 1

Severe Anxiety

• Dose: 5–10 mg IM or IV, repeat in 3–4 hours if necessary 1

Endoscopic Procedures

• IV titration: Administer slowly immediately before procedure, titrating to desired sedation (e.g., slurred speech); generally ≤10 mg adequate, up to 20 mg if narcotics omitted 1
• IM alternative: 5–10 mg approximately 30 minutes before procedure if IV unavailable 1
• Narcotic dose reduction: Reduce opioid doses by at least one-third when co-administering diazepam 1

Febrile Seizure Prophylaxis (Intermittent)

• <12 months: 2.5 mg twice daily during febrile illness 2
• 12 months–3 years: 5 mg twice daily during febrile illness 2
• >3 years: 7.5 mg twice daily during febrile illness 2
• Rationale: Intermittent prophylaxis during fever is preferred over continuous phenobarbital or valproic acid due to lower toxicity burden for benign febrile seizures 2
• Efficacy trade-off: Reduced prophylactic diazepam use increases 24-hour seizure recurrence from 12% to 20%, but avoids chronic benzodiazepine exposure 5

Common Pitfalls and Contraindications

Route Selection Errors

• Avoid intramuscular route for seizures: IM absorption is unpredictable and risks tissue necrosis; use IV or rectal routes 2
• Avoid small veins: Do not use dorsal hand or wrist veins; risk of extravasation and thrombophlebitis 1

Dosing Errors

• Do not dilute or mix: Never dilute diazepam or mix with other drugs in syringe or infusion container 1
• Infusion tubing: If direct IV administration not feasible, inject slowly through infusion tubing as close to vein insertion as possible 1

Monitoring Failures

• Chronic lung disease: Exercise extreme caution in patients with chronic pulmonary disease or unstable cardiovascular status 1
• Prolonged observation: Active metabolites persist; monitor for re-sedation and respiratory depression for several hours after last dose 1

Comparative Agent Considerations

• Lorazepam superiority for status epilepticus: Lorazepam provides longer anticonvulsant duration (hours vs. 15–20 minutes) and is often preferred over diazepam for status epilepticus 2, 6
• Midazolam for recurrent seizures: Midazolam demonstrates superior efficacy for recurrent seizures or status epilepticus (40±32 minutes vs. 69±24 minutes seizure control time) with similar safety profile 7